NOTCH4
protein-codingnotch receptor 4, the group of Notch receptors
Gene summary
This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor may play a role in vascular, renal and hepatic development. Mutations in this gene may be associated with schizophrenia. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
- INT3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~29.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NOTCH4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004557.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 9 | 9 | 21 | ||
| missense | 229 | 12 | 5 | 246 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 237 | 21 | 14 | 272 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004548.3 | 30 | MANE Select | |
| Ensembl | ENSP00000364163.3 | 30 | MANE Select | |
| Ensembl | ENSP00000553303.1 | 30 | Standard | |
| Ensembl | ENSP00000553304.1 | 29 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Breast cancer - Homo sapiens (human)
- Thyroid hormone signaling pathway - Homo sapiens (human)
- MicroRNAs in cancer - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
- Notch signaling pathway - Homo sapiens (human)
Biological Process
- branching involved in blood vessel morphogenesis
- cell fate determination
- morphogenesis of a branching structure
- endothelial cell morphogenesis
- vasculature development
Molecular Function
- calcium ion binding
- protein binding
- signaling receptor activity
- protein heterodimerization activity
Cellular Component
- Golgi membrane
- extracellular region
- nucleus
- nucleoplasm
- endoplasmic reticulum membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375023
- Coding exons
- 30
- Length
- 29225
- Individuals with no LoFs
- 125564
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 184
- Defined
- 125748
- p
- 0.000732
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.14 | 937 | 1.14e+3 | 0.822 | 0.0000616 | 12764 |
| Missense (PolyPhen) | 379 | 460.99 | 0.82215 | 5314 | ||
| Synonymous | 3.02 | 378 | 460 | 0.821 | 0.0000252 | 4191 |
| Loss of Function | 3.56 | 51 | 86.8 | 0.588 | 0.00000432 | 977 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.00098 | notable |
| Latino/Admixed American | 0.0011 | 0.0011 | notable |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00083 | 0.00082 | rare |
| Finnish | 0.00024 | 0.00023 | rare |
| European (Non-Finnish) | 0.00066 | 0.00062 | rare |
| South Asian | 0.0011 | 0.0010 | notable |
| Other | 0.00067 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. May regulate branching morphogenesis in the developing vascular system (By similarity). {ECO:0000250}.;
Intolerance Scores
- LoFtool
- 0.138
- RVIS EVS
- 0.15
- RVIS percentile EVS
- 64.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.946
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |